期刊文献+

老年患者肺部感染的病原菌分布特点及抗菌药物使用分析 被引量:2

Bacterial Distribution and Usage of Antibacterials in Senile Patients with Bacterial Pneumonia
下载PDF
导出
摘要 目的:了解我院老年细菌性肺炎的感染及治疗的基本情况,以期为临床用药提供参考数据。方法:对我院2007年2月-2008年3月住院的118例老年细菌性肺炎患者的病原学检查结果、感染部位、抗菌药物应用情况及治疗结果等进行回顾性分析。结果:病原菌以凝固酶阴性葡萄球菌、鲍曼不动杆菌和铜绿假单胞菌为主,感染率依次为21.05%,19.74%,14.47%;临床上多使用头孢哌酮(15.21%)、左氧氟沙星(20.85%)、哌拉西林(8.45%)或联用其他抗菌药物治疗老年细菌性肺炎。结论:病原菌以革兰阴性杆菌为主,革兰阳性球菌亦有较大比例;抗菌药物的应用基本合理。 Objective: To investigate the infection and treatment of bacterial pneumonia in senile patients in our hospital to provide the reference for the clinical medication. Methods: The hospitalized records of the 118 senile patients with bacterial pneumonia from February 2007 to March 2008 were retrospectively analyzed. Results: The main pathogens were coagulase negative Staphylococcus (CONS), A. baumannii and P. aerugiuosa. The infection rate were 21.05%, 19.74% and 14.47% respectively. In clinic, cefoperazone(15.21%),levofloxacin(20.85%) ,piperacillin(8.45%) and combined use of other antibiotics for treating bacterial pneumonia in senile patients were used commonly. Conclusion: Gram negative bacterium is the dominant pathogen, gram-positive cocci also has the great ratio. The usage of antibiotics is basically reasonable.
出处 《中国药物应用与监测》 CAS 2009年第3期156-158,共3页 Chinese Journal of Drug Application and Monitoring
关键词 老年 细菌性肺炎 病原菌 抗菌药物 Elderly Bacterial pneumonia Pathogenic bacteria Antibacterial agents
  • 相关文献

参考文献4

二级参考文献26

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献5188

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部